PARP1 and osteoporosis: In this regard, PARP1 and its PARylating activity exert influence over osteoclast differentiation and bone remodeling via NF-κB dependent transcription of IL-1β [39], and glucocorticoid-induced osteoporosis is a consequence of the inhibition of IL-1 production [52].